Pharmaceutical Commerce - July/August 2011

Long used in clinical research, cloud computing is now entering commercial and business applications

Pharmaceutical Anti-Counterfeiting: Combating the Real Danger from Fake Drugs

SAS’ new Center for Health Analytics will expand statistical applications

Cloud-based collaboration system provides for production, status and now quality interactions between business partners

Satellite and cellular technologies, combined with advanced electronic sensors are creating new options for pharma shippers

Following FDA’s punt of regulations for social media, industry is scratching its collective head over how to utilize these channels

Structured product labeling--along with more formalized methods of tracking changes--seek to improve patient safety

Recognizing the realities of how new product launches enter the market

Phoenix, AZ, facility will support research and commercialization efforts for imaging agents and biomarkers

Industry and FDA can—and must—do more to protect global pharmaceutical supply chains

Company says that its focus is on best value for payers, patients while meeting manufacturers’ needs through a ‘compressed’ supply chain

Paris-based Kadrige is opening its first US office in Quintiles’ New Jersey regional center; companies will co-promote the Kadrige live e-detailing platform for sales reps

Google and other web search engines have already tightened their controls for online pharmacy advertising; now they know the penalty for not doing so

Report also raises concerns over lack of quality control in the gray market as short-supply conditions increase

Asian companies are expanding out from region faster than other countries are moving in

Industry is reacting to the changing environment by reducing sales investment; watch out for declining access to oncologists

The industry is far from ready when it comes to collecting, aggregating, cleansing and disclosing data about regulated financial transactions with doctors and hospitals

DEA suspends the license of another wholesaler over unmonitored shipments of controlled substances, including oxycodone

Competitive analysis of manufacturers’ products is one potential commercial offering

The business of analyzing prescriber data is consolidating around IMS Health

Industry veteran Harvey Tannenbaum retires

Industry events showcase wholesalers’ commitment to the independent channel

Phoenix, AZ, facility will support research and commercialization efforts for imaging agents and biomarkers

Regional pharmacy benefit manager is on a growth curve

The $29.1B proposed merger brings more pressure onto manufacturers as buyers consolidate

New distribution centers in Asia, Europe and North America will add over 600,000 sq. ft of dedicated warehouse capacity for life sciences

Big Brown will handle warehousing and transportation globally, on a non-exclusive basis

Founder of the third of the Big Three wholesalers passes on the reins